Concepedia
Statistics
Publications
3
Citations
53
H-Index
Active since
2024
Affiliations
Seoul National University Hospital(Current)
Toranomon Hospital
Samsung Medical Center
Koo Foundation Sun Yat-Sen Cancer Center
Aichi Cancer Center
Hiroji Iwata is an author at Seoul National University Hospital specializing in oncology, pembrolizumab therapy, and medicine.
Publications per year
2024–2025
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial
Shanu Modi, William Jacot, Hiroji Iwata et al. · Nature Medicine · 2025 · 22 citations · Full text
Medicine, Oncology, Pharmacology +15
Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC
Seock‐Ah Im, Javier Cortés, David W. Cescon et al. · npj Breast Cancer · 2024 · 21 citations · Full text
Medicine, Oncology, Pharmacology +6
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai et al. · npj Breast Cancer · 2024 · 10 citations · Full text
Medicine, Oncology, Pharmacology +16
1–3 of 3